Wednesday, June 25, 2014

Top Blue Chip Stocks To Watch Right Now

With shares of Dell (NASDAQ:DELL) trading around $12, is DELL an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

Dell is a global information technology company that offers its customers a range of solutions and services, which are delivered directly by Dell, as well as other distribution channels. The company operates in four segments: Large Enterprise, Public, Small and Medium Business, and Consumer. Dell serves a wide range of customers: global and national corporate businesses; educational institutions; government, health care, and law enforcement agencies; small and medium-sized businesses; as well as end users. Through its four segments, Dell is able to provide information technology products to a growing user base around the world.

Dell shareholders are due to vote on founder Michael Dell�� $24.4 billion buyout offer today, but some are expecting the vote to be postponed again as Mr. Dell works to drum up support for his bid. Dell is competing against billionaire Carl Icahn to take the struggling the company private. Dell shareholders are in a predicament: many don�� feel that Dell�� offer is high enough, but they also recognize that the company�� stock could take a major hit the longer the uncertainty lasts.

Hot Sliver Companies To Own For 2015: TMS International Corp.(TMS)

TMS International Corp., through its subsidiaries, provides outsourced industrial services to steel mills in North America and internationally. It principally offers scrap management and preparation; semi-finished and finished material handling; metal recovery and slag handling, processing, and sales; surface conditioning; raw materials procurement and logistics; and proprietary software-based raw materials cost optimization services. The company?s scrap management and preparation services include the provision of inspection, preparation, and delivery of raw materials, primarily scrap, as well as inventory control through logistics management services. Its semi-finished and finished material handling services comprise handling and transportation of semi-finished and finished steel products, such as steel slabs, billets, and plates; metal recovery and slag handling, processing, and sales services consist of recycling and processing the slag to recover metallic material; an d surface conditioning services include removing imperfections from semi-finished steel products to be used in applications that require unblemished finishes, such as household appliances and automobiles. The company?s raw materials procurement and logistics services comprise purchasing, on behalf of customers, raw material inputs, including ferrous scrap, scrap substitutes, coke, coal, ore, non-ferrous metals, ferro-alloys, and other raw materials used in steel making, as well as arranging point-to-point delivery logistics. Its proprietary software-based raw materials cost optimization services consist of development and marketing of Scrap OptiMiser and GenBlend software applications that aid mills in the planning, procurement, and utilization of ferrous scrap and scrap substitutes. The company was founded in 1926 and is headquartered in Glassport, Pennsylvania. TMS International Corp. is a subsidiary of Onex Corporation.

Advisors' Opinion:
  • [By Rich Duprey]

    Outsourced industrial services provider�TMS International (NYSE: TMS  ) announced on Friday its second-quarter dividend of $0.10 per share, the same rate it paid last quarter after initiating the payout.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on TMS International (NYSE: TMS  ) , whose recent revenue and earnings are plotted below.

10 Best Information Technology Stocks To Buy Right Now: Stillwater Mining Company(SWC)

Stillwater Mining Company engages in developing, extracting, processing, smelting, refining, and marketing palladium, platinum, and platinum group metals (PGMs). The company conducts its mining operations at the Stillwater mine, which is located near Nye, Montana; and at the East Boulder mine located near Big Timber, Montana. It is also involved in developing Marathon, a PGM/copper property, which is located in Ontario, Canada; and exploring Altar, a copper/gold property located in San Juan, Argentina. In addition, the company operates a smelter and base metal refinery located in Columbus, Montana. Further, it recycles spent catalyst material to recover palladium, platinum, and rhodium at its smelter and base metal refinery. As of December 31, 2011, the company had proven and probable ore reserves of approximately 42.5 million tons at its Montana operations; and approximately 91.4 million tones at the Marathon development project. Stillwater Mining Company was founded in 1 992 and is headquartered in Billings, Montana.

Advisors' Opinion:
  • [By Dan Caplinger]

    4. Platinum-group metals
    Platinum and palladium both fell sharply, losing 5% and 6% of their value, respectively. Those losses weren't as extreme as gold's, but they nevertheless represented a drop to levels not seen since late last year. The two major miners producing the white metals, Stillwater Mining (NYSE: SWC  ) and North American Palladium (NYSEMKT: PAL  ) , both lost more than 10% on the day.

10 Best Information Technology Stocks To Buy Right Now: Acorn Energy Inc.(ACFN)

Acorn Energy, Inc., through its subsidiaries, provides technology driven solutions for energy infrastructure asset management worldwide. It offers sonar and acoustic related solutions for energy, defense, and commercial markets with a focus on underwater site security for strategic energy installations and other acoustic systems, as well as develops and produces real-time embedded hardware and software. The company also develops and markets remote monitoring systems to electric utilities and industrial facilities, which are used in a range of utility applications, including outage management, power quality monitoring, system planning, trouble shooting and proactive maintenance, and condition monitoring; and provides the intelligence to transmission and distribution network operators. In addition, it develops and produces fiber optic sensing systems for the energy, commercial security, and defense markets. The company?s patented ultra-high sensitivity fiber optic sensors a re designed to replace electronic sensors with fiber optic sensors. Further, it engages in the design, manufacture, marketing, and sale of wireless remote systems that monitor standby power generation, backup power generators, remote powered equipment, cellular towers, emergency towered communications, and remote tower sites; cathodic protection products to monitor pipeline integrity; and other wireless remote systems. Acorn Energy, Inc. was founded in 1986 and is based in Montchanin, Delaware.

Advisors' Opinion:
  • [By Roberto Pedone]

    A technology stock that's starting to move within range of triggering a big breakout trade is Acorn Energy (ACFN), which provides digital solutions for energy infrastructure asset management. This stock has been hit hard by the sellers in 2013, with shares off sharply by 48%.

    If you take a look at the chart for Acorn Energy, you'll notice that this stock has started to spike higher here back above its 50-day moving average of $3.66 a share. This stock has also found significant buying interest over the last two months, each time it has pulled back to around $3.50 to $3.20 a share. Shares of ACFN are now quickly moving within range of triggering a big breakout trade above some key near-term overhead resistance levels.

    Traders should now look for long-biased trades in ACFN if it manages to break out above some key near-term overhead resistance levels at $4.24 to $4.64 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 344,835 shares. If that breakout triggers soon, then ACFN will set up to re-test or possibly take out its next major overhead resistance levels at $5.50 to $6 a share. Any high-volume move above $6 will then put its next major overhead resistance levels at its 200-day moving average of $6.35 to $6.68 a share into range for shares of ACFN.

    Traders can look to buy ACFN off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $3.66 a share, or right around some major support at $3.21 a share. One could also buy ACFN off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

10 Best Information Technology Stocks To Buy Right Now: IDEXX Laboratories Inc (IDXX)

IDEXX Laboratories, Inc., incorporated in 1983, develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The Company operates through three segments: diagnostic and information technology-based products and services for the veterinary market, which it refers to as the Companion Animal Group (CAG), water quality products (Water) and products for livestock and poultry health, which it refer to as Livestock and Poultry Diagnostics (LPD). It also operates two smaller segments that consist of products for milk quality and safety (Dairy) and products for the human point-of-care medical diagnostics market (OPTI Medical). In November 2011, the Company acquired the research and diagnostic laboratory (RADIL) business of the College of Veterinary Medicine from the University of Missouri. In August 2013, IDEXX Laboratories, Inc. announced that it has acquired Madasa do Brasil Ltda.

The Company sells a range of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its primary products and services are point-of-care veterinary diagnostic products, consisting of instruments and consumables and rapid assays; veterinary reference laboratory diagnostic and consulting services used by veterinarians; diagnostic and health-monitoring products for livestock and poultry; products that test water for certain microbiological contaminants; practice management systems and services and digital radiography systems used by veterinarians; products that test milk for antibiotic residues and other contaminants, and point-of-care electrolytes and blood gas analyzers used in the human point-of-care medical diagnostics market.

Companion Animal Group

The Company markets a range of in-clinic laboratory analyzers for use in providing reference laboratory quality diagnostic results in companion animal veterinary practices, which it refers ! to as the IDEXX VetLab suite of analyzers. The Company sells two chemistry analyzers, the Catalyst Dx Chemistry Analyzer and the VetTest Chemistry Analyzer, that are used by veterinarians to measure levels of certain enzymes and other substances in blood or urine for monitoring health status and assistance in diagnosing physiologic conditions. Both instruments use consumables manufactured for IDEXX by Ortho-Clinical Diagnostics, Inc. (Ortho), a subsidiary of Johnson & Johnson, based on Ortho�� dry slide technology (Catalyst Dx slides, VetTest slides or slides). In addition, the Catalyst Dx analyzer also uses dry slide electrolyte consumables manufactured by IDEXX at OPTI Medical Systems, one of its wholly owned subsidiaries. Blood tests commonly run on these analyzers include glucose, alkaline phosphatase, alanine aminotransferase (ALT), albumin, creatinine, blood urea nitrogen (BUN), and total protein. Tests are sold individually and in prepackaged panels. Both analyzers also run a urine test called urine protein:creatinine ratio, which assists in the detection of early renal disease.

The Catalyst Dx analyzer is the Company�� chemistry analyzer. The Catalyst Dx analyzer allows a veterinarian to run multiple patient samples simultaneously; to run different sample types, including whole blood, plasma, serum and urine; to perform 28 different chemistry and electrolyte tests; and to automatically calculate other parameters and ratios important to blood chemistry analysis. Its VetLyte Electrolyte Analyzer measures three electrolytes-sodium, potassium and chloride-to aid in evaluating acid-base and electrolyte balances and assessing plasma hydration. Its VetStat Electrolyte and Blood Gas Analyzer measures electrolytes, blood gases, glucose and ionized calcium, and calculates other parameters, such as base excess and anion gap. These measurements aid veterinarians in diagnosing various disease states, evaluating fluid therapy choices and measuring respiratory function. The VetStat analyzer ru! ns single! -use disposable cassettes that contain various configurations of analytes. The VetStat analyzer and its cassettes are manufactured by OPTI Medical Systems.

The Company sells three hematology analyzers that assess the cellular components of blood, including red blood cells, white blood cells and platelets (also called a complete blood count (CBC)). These analyzers include the ProCyte Dx Hematology Analyzer, which uses laser-flow cytometry, optical fluorescence and laminar-flow impedance in its analysis; the LaserCyte Hematology Analyzer, which uses laser-flow cytometry technology in its analysis, and the IDEXX VetAutoread Hematology Analyzer. It also sells the Coag Dx Analyzer, which permits the detection and diagnosis of blood clotting disorders. The ProCyte Dx analyzer provides validated results for five species (canine, feline, equine, bovine and ferret) for up to 24 different blood parameters, providing a more complete picture of each patient�� health.

The SNAPshot Dx analyzer provides quantitative measurements of total thyroxine (T4), cortisol and bile acids to assist in the evaluation of thyroid, adrenal and liver function. The SNAPshot Dx analyzer also reads, interprets and records the results of many IDEXX rapid assay SNAP tests, including its canine SNAP 4Dx test, feline SNAP FIV/FeLV Combo test, canine SNAP cPL test, feline SNAP fPL test, SNAP Feline Triple test and canine SNAP Heartworm RT test. The IDEXX VetLab UA Analyzer provides chemical urinalysis and is validated specifically for veterinary use. The IDEXX VetLab Station (IVLS) connects and integrates the diagnostic information from all the IDEXX VetLab equipment and thus provides reference laboratory information management system capability. It sells the IVLS as an integral component of the Catalyst Dx, LaserCyte and ProCyte Dx analyzers and also as a standalone hardware platform.

The IVLS includes a user interface to input patient information, connect with a practice management system and send i! nformatio! n to run the individual analyzers. IVLS also generates one integrated patient report incorporating all of the lab work generated by the IDEXX VetLab suite; stores, retrieves and analyzes historical patient diagnostics data, including SNAP test results; and sends and receives information from practice management systems, including the IDEXX Cornerstone system, as well as a variety of third-party systems. It sells a range of single-use, handheld test kits under the SNAP name. In addition to its single-use tests, it sells a range of microwell-based test kits under the PetChek name for canine heartworm, FIV and FeLV.

The Company offers commercial reference laboratory diagnostic and consulting services to veterinarians in the United States, Canada, Europe, Australia, Japan, South Africa, China and South Korea and to bioresearch customers in the United States and Europe. The Company provides specialized veterinary consultation, telemedicine and advisory services, including radiology, cardiology, internal medicine and ultrasound consulting. It develops, markets and sells practice management systems, including hardware and software, and services that run certain functions of veterinary clinics, including managing patient electronic health records, scheduling (including boarding and grooming), reminders, billing and inventory management.

The Company markets and sells two digital radiography systems for use in the small animal veterinary hospital: the IDEXX-DR 1417 and the IDEXX I-Vision CR. Its digital radiography systems use IDEXX-PACS and IDEXX EquiView PACS picture archiving and communication system (PACS) software for the viewing, manipulation, management, storage and retrieval of the digital images generated by the digital capture plate. In September 2011, the Company launched IDEXX I-Vision Mobile, an application that allows veterinarians with the IDEXX-DR 1417 and IDEXX I-Vision CR systems, as well as its digital radiography systems, to request, view and send images using an iPa! d or an A! ndroid mobile tablet. This application integrates with its IDEXX-PACS software.

Water

The Company offers a range of products used in the detection and quantification of various microbiological parameters in water. Its principal products are the Colilert, Colilert-18 and Colisure tests, which simultaneously detect the presence of total coliforms and E. coli in water. These organisms are used as indicators of microbial contamination in water. These products utilize indicator-nutrients that produce a change in color or fluorescence when metabolized by target microbes in the sample. Its water tests are used by government laboratories, water utilities and private certified laboratories to test drinking water. The tests also are used in evaluating water used in production processes (for example, in beverage and pharmaceutical applications) and in evaluating bottled water, recreational water, waste water and water from private wells.

Livestock and Poultry Diagnostics

The Company sells diagnostic tests and related instrumentation that are used to detect a range of diseases and to monitor health status in livestock and poultry. Its livestock and poultry diagnostic products are purchased by government and private laboratories that provide testing services to cattle, swine and poultry veterinarians and producers. Its principal products include tests for Bovine Viral Diarrhea Virus (BVDV), Porcine Reproductive and Respiratory Syndrome (PRRS) and Bovine Spongiform Encephalopathy (BSE or mad cow disease). BVDV is a common and contagious viral infection that suppresses the immune system, making the animal susceptible to a host of other infections, impacting beef and dairy production yields as a result. PRRS is a contagious virus causing reproductive problems and respiratory diseases. BSE is a fatal neurodegenerative disease in cattle that causes a spongy degeneration in the brain and spinal cord.

Other

The principal products in the Company�! � Dairy ! business are its SNAP tests used to detect antibiotic drug-residue in milk. Its primary product line for detecting antibiotic residue in milk is SNAP Beta-Lactam, which detects penicillin, amoxicillin, ceftiofur and cephaphirin residues, followed by SNAPduo Beta-Tetra, which detects certain tetracycline antibiotic residues in addition to those detected by the SNAP Beta Lactam test kits. It also sells SNAP tests for the detection of certain other contaminants in milk, such as chemical melamine and Alfatoxin M1.

The Company sells OPTI point-of-care analyzers and related consumables for use in human medical hospitals and clinics to measure electrolytes, blood gases, acid-base balance, glucose, lactate, BUN and ionized calcium, and to calculate other parameters, such as base excess and anion gap. These analyzers are used primarily in emergency rooms, operating rooms, cardiac monitoring areas and other locations where time-critical diagnostic testing is performed within the hospital setting. The OPTI CCA and OPTI Touch Electrolyte and Blood Gas Analyzers run single-use disposable cassettes that contain various configurations of analytes; the OPTI R Analyzer runs reusable cassettes in various analyte configurations; and the OPTI LION Stat Electrolyte Analyzer runs single-use electrolyte cassettes. OPTI Medical Systems also manufactures its VetStat analyzer and provides the electrolyte module and dry slide reagents that make up the electrolyte testing functionality of the Catalyst Dx analyzer.

The Company competes with VCA Antech, Inc., Abaxis, Inc., Butler, Radiometer A/S, Siemens Medical Solutions Diagnostics, Instrumentation Laboratory, Abbott Diagnostics and Roche Diagnostics.

Advisors' Opinion:
  • [By CanadianValue]

    Idexx (IDXX) performed well in 2011, generating solid revenue growth and high-teens earnings growth thanks to a slight recovery in the veterinary end market, the ramp up of its new ProCyte hematology instrument, continued share gains in reference laboratories and one-time gains from production animal disease eradication programs in Europe. While we continue to like the company�� prospects and are impressed with its execution in a still sluggish market for animal healthcare, we trimmed our position in 2011 at prices we found attractive given our expectations for the business.

  • [By Sean Williams]

    Ignore this trend at your own risk
    If you choose to do nothing, then you're playing right into the hands of pharmaceutical giants like Zoetis (NYSE: ZTS  ) , Merck (NYSE: MRK  ) , and IDEXX Laboratories (NASDAQ: IDXX  ) , which are counting on your indifference to drive their profits.

  • [By Tim Brugger]

    After 10 years on the board of IDEXX Laboratories (NASDAQ: IDXX  ) , including serving on its audit and compensation committees, Brian McKeon has been named IDEXX's new executive vice president and CFO, the company announced today. McKeon's appointment as CFO becomes effective Jan. 1, though he has resigned from the IDEXX board as of Oct. 11, the company said.

  • [By Sean Williams]

    On the diagnostic side, there isn't a company better equipped to help veterinarians diagnose bone and organ disease, or help veterinarians improve the efficiency of their software, than IDEXX Laboratories (NASDAQ: IDXX  ) . From small diagnostic analyzers to high-tech digital imagery and even consultation calls, IDEXX does it all for owners and veterinarians. The best part is that the company's companion diagnostics make up the bulk (83%) of its revenue, so the chance of IDEXX seeing a slowdown in demand appears pretty minimal.

10 Best Information Technology Stocks To Buy Right Now: Morningstar Inc.(MORN)

Morningstar, Inc., together with its subsidiaries, provides independent investment research to investors worldwide. The company operates in two segments, Investment Information and Investment Management. The Investment Information segment offers data, software, and research products and services for individual investors, financial advisors, and institutional clients. It provides Licensed Data, a set of investment data spanning various investment databases, including real-time pricing data available through electronic data feeds; Morningstar Advisor Workstation, a Web-based investment planning system; Morningstar.com, a membership service and Internet advertising space; Morningstar Direct, a Web-based institutional research platform; integrated Web tools to build customized Websites or enhance existing sites; Morningstar Principia, a CD-ROM-based investment research and planning software; Morningstar commodity data that provides data and analytics for the energy, financial, and agriculture sectors; equity and corporate credit research; and Morningstar structured credit ratings and research services. This segment also offers various financial communications materials, real-time data and desktop software, investment software, and investment indexes, as well as various print and online publications. The Investment Management segment offers various products and services, such as Investment Consulting that focuses on investment monitoring and asset allocation for funds of funds, including mutual funds and variable annuities; Retirement Solutions comprising the Morningstar Retirement Manager and Advice by Ibbotson platforms; and Morningstar Managed Portfolios, a asset management service includes series of mutual fund, exchange-traded fund, and stock portfolios. This segment serves banks, brokerage firms, insurance companies, mutual fund companies, and retirement plan sponsors and providers. Morningstar, Inc. was founded in 1984 and is headquartered in Chicago, Illinois.

Advisors' Opinion:
  • [By Reuters]

    Simon Dawson/Bloomberg via Getty Images TORONTO -- BlackBerry reported a quarterly loss of nearly $1 billion Friday, in line with last week's warning, days after accepting its largest shareholder's tentative $4.7 billion bid to take it out of the public eye. BlackBerry (BBRY), which had warned of poor results on Sept. 20, said its net loss for the second quarter ended on Aug. 31 was $965 million, or $1.84 a share. Revenue fell 45 percent to $1.6 billion from a year earlier. The loss included a writedown of about $934 million for unsold Z10 phones, a touchscreen model that the company had hoped would reverse its fading fortunes. The phone has sold badly with business and consumer customers alike. "This write-off is very real," said Morningstar (MORN) analyst Brian Colello. "They bought a lot of inventory hoping to sell it. The auditors were not convinced that BlackBerry can sell it or sell it at prices that the company was hoping for. We see no reason to be more optimistic than them." Excluding the Z10 writedown and restructuring costs, BlackBerry reported a loss of $248 million, or 47 cents a share. The company plans to shed 4,500 jobs, or more than one-third of its workforce, as it shrinks to focus on corporate and government customers. It will not host the typical post-results call for investors after signing a tentative $9-a-share agreement to be acquired by a consortium led by Fairfax Financial, its largest shareholder, Monday. The Waterloo, Ontario-based company's steep revenue decline and mounting losses have revived fears that BlackBerry, a pioneer in the smartphone sector, faces an ignominious death. "We are very disappointed with our operational and financial results this quarter and have announced a series of major changes to address the competitive hardware environment and our cost structure," Chief Executive Officer Thorsten Heins said in the earnings statement. BlackBerry said Heins wasn't available for an interview. The company said it

  • [By Reuters]

    Mark Lennihan/APAbercrombie & Fitch CEO Michael Jeffries An Abercrombie & Fitch shareholder urged the teen apparel retailer to replace Chief Executive Officer Mike Jeffries after his contract expires in February, failing which the company should look to sell itself. Engaged Capital, which owns less than 1 percent of the company's shares, said in a letter to the board Tuesday that the expiration of Jeffries' term is an opportunity for the board to set a new direction for the company. Engaged Capital, a young activist investment firm led by former Relational Investors managing director Glenn Welling, said a sale of the company to a private equity buyer may represent the best option for shareholders. "However, as we have learned through discussions with industry insiders and private equity firms, Mr. Jeffries' presence represents a major stumbling block to a transaction," the activist investment firm said in the letter. Abercrombie's (ANF) shares, which have lost about 30 percent of their value this year, rose 6.4 percent to $36.20 by midday. Analysts have raised concerns about the company's ability to revitalize its merchandise, citing management's focus on cost-cutting, marketing and distribution instead of product and design. "A little fresh blood would definitely benefit the company," Morningstar (MORN) analyst Bridget Weishaar told Reuters. However, she said the board has been very supportive of Jeffries. "So, I'd be highly doubtful if this letter changes anything." Engaged Capital said there appeared to be no qualified successor within the company to replace 69-year-old Jeffries, who has been CEO for 16 years. His current contract includes a clause that he would receive over $100 million if the company changes control. Jeffries owned about 1.3 percent of Abercrombie's shares as of July 30. The company wasn't immediately available for comment. Engaged Capital said it owned about 400,000 shares of Abercrombie. The company has about 76.4 mil

10 Best Information Technology Stocks To Buy Right Now: Maxwell Technologies Inc.(MXWL)

Maxwell Technologies, Inc., together with its subsidiaries, develops, manufactures, and markets energy storage and power delivery products, and microelectronic products worldwide. The company offers Ultracapacitors that are energy storage devices to provide energy storage and power delivery solutions for applications in transportation, automotive, information technology, renewable energy, and industrial electronics industries; and CONDIS high-voltage capacitors comprising grading and coupling capacitors, and capacitive voltage dividers used to ensure the safety and reliability of electric utility infrastructure and other applications involving transport, distribution, and measurement of high-voltage electrical energy. It also provides radiation-hardened microelectronic products, including single board computers and components, such as high-density memory and power modules for satellites and spacecraft applications. The company markets and sells its products through direct and indirect sales for integration by original equipment manufacturers into a range of end products. The company was formerly known as Maxwell Laboratories, Inc. and changed its name to Maxwell Technologies, Inc. in 1996. Maxwell Technologies was founded in 1965 and is headquartered in San Diego, California.

Advisors' Opinion:
  • [By Roberto Pedone]

    Maxwell Technologies (MXWL) develops, manufactures and markets energy storage and power delivery products for transportation, industrial telecommunications and other applications and microelectronic products for space and satellite applications. This stock closed up 3.7% to $9.50 in Tuesday's trading session.

    Tuesday's Range: $9.07-$9.54

    52-Week Range: $4.90-$11.08

    Tuesday's Volume: 369,000

    Three-Month Average Volume: 360,477

    From a technical perspective, MXWL spiked notably higher here right above some near-term support at $9 with above-average volume. This stock has been consolidating and trending sideways for the last two months, with shares moving between $8.61 on the downside and $10.39 on the upside. Shares of MXWL are now quickly moving within range of triggering a near-term breakout trade above the upper-end of its recent sideways trading chart pattern. That trade will hit if MXWL manages to take out Tuesday' high of $9.54 and then once it clears more near-term overhead resistance at $10.39 with high volume.

    Traders should now look for long-biased trades in MXWL as long as it's trending above its 50-day at $8.81 and then once it sustains a move or close above those breakout levels with volume that's near or above 360,477 shares. If that breakout hits soon, then MXWL will set up to re-test or possibly take out its 52-week high at $11.08. Any high-volume move above that level will then give MXWL a chance to tag $12.

10 Best Information Technology Stocks To Buy Right Now: lululemon athletica inc.(LULU)

Lululemon Athletica Inc., together with its subsidiaries engages in the design, manufacture, and distribution of athletic apparel and accessories for women, men, and female youth primarily in Canada, the United States, and Australia. Its apparel assortments include fitness pants, shorts, tops, and jackets for healthy lifestyle activities, such as yoga, running, and general fitness. The company?s fitness-related accessories comprise bags, socks, underwear, yoga mats, instructional yoga DVDs, and water bottles. It sells its products through its retail stores; independent franchises; and a network of wholesale accounts, such as yoga studios, health clubs, and fitness centers, as well as directly to consumers through e-commerce. As of May 1, 2011, the company had 142 corporate-owned and franchise stores under the lululemon athletica and ivivva athletica brand names. Lululemon Athletica Inc. was founded in 1998 and is based in Vancouver, Canada.

Advisors' Opinion:
  • [By Ben Levisohn]

    Shares of Lululemon (LULU) have dropped 8.9% this year, all the more impressive given the S&P 500′s 25% rise in 2013. Even worse, comparable stores Urban Outfitters (URBN), Ross Stores (ROST) and Guess? (GES) have all gained between 1.5% and 47% so far this year.

    In fact, everything that could go wrong for Lululemon did go wrong. Its earnings have disappointed. Its margins have been weakening. And then there was the issue with its see-through pants. The less said about that, the better.

    But now JPMorgan’s Brian Tunick and Kate Fitzsimons have a message for all of Lululemon’s detractors: 2014 will be much better than 2013. They write:

    After a 2013 wrought with execution issues, we see multiple levers to reaccelerate top- and bottom-line growth in FY14 and beyond, driven by low- to midteens footage growth, HSD-LDD comp gains, double-digit online growth, and margin recovery over time. 2014 potential catalysts for lulu include: 1) lapping the easier comp and margin comparisons from the 2013 Luon recall; 2) appointment of a new CEO, who could be showcased at the brand�� April Analyst Day; and 3) lulu�� first European store opening in London in 2Q14. LULU�� multiple��hile not cheap��could be poised for expansion once a new CEO is appointed and investors refocus on the brand�� top-line and margin recapture prospects in 2014 and beyond.

    Tunick and Fitzsimons start Lululemon’s shares with an Overweight rating, boosting the stock to a 3.8% gain. Their $84 price target is 21% higher than Lululemon’s last trade of $69.53 at 2:41 p.m.

No comments:

Post a Comment